NEW YORK (

TheStreet

) -- Shares of

BioMimetic Therapeutics

(Nasdaq:

BMTI

) were gapping down Tuesday morning with an open price 28.3% lower than Monday's closing price. The stock closed at $13.39 Monday and opened today's trading at $9.60.

The average volume for BioMimetic has been 114,400 shares per day over the past 30 days. BioMimetic has a market cap of $371.8 million and is part of the

health care

sector and

health services

industry. Shares are up 5.4% year to date as of the previous trading day's close.

BioMimetic Therapeutics, Inc., a biotechnology company, engages in the development and commercialization of regenerative protein therapeutic-device combination products for the treatment of musculoskeletal injuries and conditions affecting bones, tendons, ligaments, and cartilage.

TheStreet Recommends

TheStreet Ratings rates BioMimetic as a

sell

. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself. You can view the full

BioMimetic Ratings Report

.

Get more investment ideas from our

investment research center

.

Interested in other stocks that are gapping down? Get free SMS text alerts sent to you when the action happens by texting

DOWN

to 95370 or select from

multiple alert options

.

null